Cardiac biomarkers predict 1-year mortality in elderly patients undergoing hip fracture surgery

Orthopedics

Volumn 40, Issue 3, 2017, Pages e417-e424

  Katsanos, Spyridon ^a   Mavrogenis, Andreas F ^a   Kafkas, Nikolaos ^b   Sardu, Celestino ^e   Kamperidis, Vasileios ^c   Katsanou, Panagiota ^d   Farmakis, Dimitrios ^a   Parissis, John ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d EVANGELISMOS HOSPITAL   (Greece)

^e CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ACUTE HEART FAILURE; AGE DISTRIBUTION; AGED; AREA UNDER THE CURVE; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CHROMATIN IMMUNOPRECIPITATION; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAPHY; FEMALE; HEART DISEASE; HEART INFARCTION; HEMIARTHROPLASTY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; Q WAVE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; VERY ELDERLY; BLOOD; CARDIOVASCULAR DISEASE; HEART FAILURE; HOSPITAL MORTALITY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; DEMENTIA; FEMALE; HEART FAILURE; HIP FRACTURES; HOSPITAL MORTALITY; HUMANS; MALE; MORTALITY; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; TROPONIN I;

EID: 85020211867     PISSN: 01477447     EISSN: 19382367     Source Type: Journal    
DOI: 10.3928/01477447-20170109-02     Document Type: Article

References (25)

1. Zuckerman JD. Hip fracture. N Engl J Med. 1996; 334(23):1519-1525.
2. Roche JJ, Wenn RT, Sahota O, Moran CG. Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. 2005; 331(7529):1374.
3. Roberts SE, Goldacre MJ. Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study. BMJ. 2003; 327(7418):771-775.
4. Maravic M, Ostertag A, Torres PU, Cohen-Solal M. Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int. 2014; 25(1):159-165.
5. Patel KV, Brennan KL, Brennan ML, Jupiter DC, Shar A, Davis ML. Association of a modified frailty index with mortality after femoral neck fracture in patients aged 60 years and older. Clin Orthop Relat Res. 2014; 472(3):1010-1017.
6. Staeheli JW, Frassica FJ, Sim FH. Prosthetic replacement of the femoral head for fracture of the femoral neck in patients who have Parkinson disease. J Bone Joint Surg Am. 1988; 70(4):565-568.
7. Khan MA, Hossain FS, Ahmed I, Muthukumar N, Mohsen A. Predictors of early mortality after hip fracture surgery. Int Orthop. 2013; 37(11):2119-2124.
8. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008; 10(9):824-839.
9. Karthikeyan G, Moncur RA, Levine O, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol. 2009; 54(17):1599-1606.
10. Breidthardt T, Kindler CH, Schindler C, Futterer M, Yonekawa K, Mueller C. B-type natriuretic peptide in patients undergoing orthopaedic surgery: a prospective cohort study. Eur J Anaesthesiol. 2010; 27(8):690-695.
11. Chong CP, Lim WK, Velkoska E, et al. Nterminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery. Am J Cardiol. 2012; 109(9):1365-1373.
12. Katsanos S, Babalis D, Kafkas N, et al. B-type natriuretic peptide vs. cardiac risk scores for prediction of outcome following major orthopedic surgery. J Cardiovasc Med (Hagerstown). 2015; 16(6):465-471.
13. Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and Nterminal fragment of pro-B-type natriuretic peptide. A systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014; 63(2):170-180.
14. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012; 33(20):2551-2567.
15. Redfern G, Rodseth RN, Biccard BM. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a metaanalysis. Anaesthesia. 2011; 66(7):604-610.
16. Dawson-Bowling S, Chettiar K, Cottam H, et al. Troponin T as a predictive marker of morbidity in patients with fractured neck of femur. Injury. 2008; 39(7):775-780.
17. Chong CP, van Gaal WJ, Ryan JE, Profitis K, Savige J, Lim WK. Does cardiology intervention improve mortality for post-operative troponin elevations after emergency orthopaedic-geriatric surgery? A randomised controlled study. Injury. 2012; 43(7):1193-1198.
18. van Waes JA, Nathoe HM, de Graaff JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation. 2013; 127(23):2264-2271.
19. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009; 119(17):2408-2416.
20. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007; 116(17):1971-1996.
21. Eggers KM, Venge P, Lind L. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years. Am J Cardiol. 2013; 111(1):131-136.
22. Dy CJ, McCollister KE, Lubarsky DA, Lane JM. An economic evaluation of a systemsbased strategy to expedite surgical treatment of hip fractures. J Bone Joint Surg Am. 2011; 93(14):1326-1334.
23. Nordling P, Kiviniemi T, Strandberg M, Strandberg N, Airaksinen J. Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide. BMJ Open. 2016; 6(2):e009416.
24. Gregory JJ, Kostakopoulou K, Cool WP, Ford DJ. One-year outcome for elderly patients with displaced intracapsular fractures of the femoral neck managed non-operatively. Injury. 2010; 41(12):1273-1276.
25. Bruce AJ, Ritchie CW, Blizard R, Lai R, Raven P. The incidence of delirium associated with orthopedic surgery: a meta-analytic review. Int Psychogeriatr. 2007; 19(2):197-214.